Galatea Bio Funding & Investors
Hialeah, FL
Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.
galatea.bioTotal Amount Raised: $28,656,000
Galatea Bio Funding Rounds
Series Unknown
$8,000,000
Series Unknown Investors
F-Prime CapitalCEI VenturesAlexandria Real Estate EquitiesDigitalis VenturesAME Cloud VenturesFounder CollectiveHBM GenomicsHelios Investment PartnersStanford UniversityAlix VenturesBIOHUBDebt Financing
$3,656,000
Series A
$10,000,000
Seed
$7,000,000
Seed Investors
Digitalis VenturesF-Prime CapitalEdward LandoPareto Holdings
Funding info provided by Diffbot.